Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.24 HKD | -4.29% |
|
-11.49% | -49.02% |
06-26 | MicroPort NeuroTech Limited Approves Final Dividend for the Year Ended 31 December 2023 | CI |
06-26 | Microport Neurotech Limited Announces Board and Committee Changes | CI |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-49.02% | 466M | - | ||
+13.62% | 130B | A- | ||
-9.08% | 10.81B | A- | ||
-18.14% | 7.12B | C | ||
+48.89% | 6.46B | B+ | ||
-34.21% | 3.98B | C | ||
+8.03% | 3.43B | C- | ||
-19.31% | 2.48B | B- | ||
-18.50% | 1.91B | - | ||
-24.94% | 1.66B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 2172 Stock
- Ratings MicroPort NeuroTech Limited